Clinical Trial Update: RSV Immunogenicity Study in the Elderly (RISE) [Phase 3]

View source ↗

Summary

A Phase 3 immunogenicity study evaluating an RSV vaccine in elderly participants is currently recruiting. The trial aims to assess immune responses to RSV vacci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Snippet

Sponsor: Karin Karin Loré | Conditions: RSV Immunisation | Phase 3 | Status: RECRUITING